Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method

被引:63
作者
Norris, HA
Elewski, BE
Ghannoum, MA
机构
[1] Univ Hosp Cleveland, Mycol Reference Lab, Ctr Med Mycol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
关键词
D O I
10.1016/S0190-9622(99)70392-0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
As a prerequisite to standardization of dermatophyte susceptibility testing, conditions that support optimal growth of different dermatophyte species must be established. Eighteen isolates of Trichophyton? spp. (T rubrum, T mentagrophytes, T tonsurans) were grown in 4 different media: RPMI 1640 with L-glutamine, without sodium bicarbonate and buffered at pH = 7.0; antibiotic medium #3 (Penassay); yeast nitrogen base with 0.5% dextrose buffered at pH = 7.0; and Sabouraud dextrose broth. Incubation for 6 days at 35 degrees C produced the following results: RPMI and Sabouraud dextrose supported equally sufficient growth for all strains tested; Penassay supported growth of only 33% of the isolates tested, and buffered yeast nitrogen base did not support growth of any isolates. RPMI was selected as the optimal medium, and organisms were tested at both 30 degrees C and 35 degrees C with a standardized inoculum density of 10(3) conidia/ml, No temperature differences were noted in the amount of growth of the dermatophytes tested. With RPMI at an incubation temperature of 35 degrees C, 3 inoculum sizes (10(3), 10(4), and 10(5) conidia/mL) were tested against 4 antifungal agents: griseofulvin, itraconazole, terbinafine, and fluconazole. Inoculum size did not affect minimum inhibitory concentration (MIC) results for itraconazole or terbinafine, but a larger inoculum produced a slightly higher MIC for griseofulvin and a noticeably higher MIC for fluconazole. Our data support the use of RPMI 1640, 35 degrees C, and 4 days as an incubation temperature and time, respectively, and an inoculum of 10(3) conidia/ml as optimal conditions for the determination of the antifungal susceptibility of dermatophytes.
引用
收藏
页码:S9 / S13
页数:5
相关论文
共 6 条
[1]   GRISEOFULVIN LEVELS IN STRATUM CORNEUM - STUDY AFTER ORAL ADMINISTRATION IN MAN [J].
EPSTEIN, WL ;
SHAH, VP ;
RIEGELMAN, S .
ARCHIVES OF DERMATOLOGY, 1972, 106 (03) :344-+
[2]   LEVELS OF TERBINAFINE IN PLASMA, STRATUM-CORNEUM, DERMIS EPIDERMIS (WITHOUT STRATUM-CORNEUM), SEBUM, HAIR AND NAILS DURING AND AFTER 250 MG TERBINAFINE ORALLY ONCE-DAILY FOR 7 AND 14 DAYS [J].
FAERGEMANN, J ;
ZEHENDER, H ;
MILLERIOUX, L .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (02) :121-126
[3]  
Larone D.H., 1995, MED IMPORTANT FUNGI, V3rd
[4]  
LESHER JL, 1992, CUTANEOUS FUNGAL INF, P229
[5]  
*NAT COMM CLIN LAB, 1996, M27A NAT COMM CLIN L, V17
[6]   Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro in vivo correlation data for fluconazole, itraconazole, and Candida infections [J].
Rex, JH ;
Pfaller, MA ;
Galgiani, JN ;
Bartlett, MS ;
EspinelIngroff, A ;
Ghannoum, MA ;
Lancaster, M ;
Odds, FC ;
Rinaldi, MG ;
Walsh, TJ ;
Barry, AL .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :235-247